JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watson, W. J.
Right arrow Articles by Polzin, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, W. J.
Right arrow Articles by Polzin, W. J.
© 2007 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 26:1209-1214 • 0278-4297


Case Series

Sonographic Detection of Trisomy 13 in the First and Second Trimesters of Pregnancy

William J. Watson, MD, Richard C. Miller, MD, Joseph R. Wax, MD, Wendy F. Hansen, MD, Yasuko Yamamura, MD and William J. Polzin, MD

Mayo Clinic College of Medicine, Rochester, Minnesota USA (W.J.W.); St Barnabas Medical Center, Livingston, New Jersey USA (R.C.M.); Maine Medical Center, Portland, Maine USA (J.R.W.); University of Kentucky, Lexington, Kentucky USA (W.F.H.); University of Minnesota, Minneapolis, Minnesota USA (Y.Y.); and Good Samaritan Medical Center, Cincinnati, Ohio USA (W.J.P.).

Address correspondence to William J. Watson, MD, Department of Maternal-Fetal Medicine, Mayo Clinic College of Medicine, 200 First St SW, Charlton 3B, Rochester MN 55905 USA. E-mail: watson.william{at}mayo.edu

Objective. The purpose of this study was to examine sonographic findings in fetuses with trisomy 13. Methods. A retrospective review of the cytogenetic laboratory databases at 6 tertiary referral centers identified all cases of trisomy 13. The prenatal sonographic studies in fetuses of less than 22 weeks’ gestation, done before invasive testing for karyotype, were reviewed for anatomic and biometric findings. We defined abnormal fetal biometric findings as a biometric measurement (biparietal diameter, abdominal circumference, or femur length) below the fifth percentile in the second trimester. Results. There were 8 cases of trisomy 13 found in the first trimester and 54 cases found in the second trimester, a total of 62 in all. In the first trimester, 6 of 8 had an anomaly identified (4 with cystic hygroma). In the second trimester, 49 of 54 were identified by sonography; 45 had an anomaly, and 4 had an abnormal fetal biometric measurement without an anomaly. The 5 missed diagnoses had early gestational age (<17 weeks; n = 3) or an inadequate survey secondary to poor visualization. Overall, 22 of 54 fetuses with trisomy 13 had an abnormal biometric measurement. The most common anomalies detected in the second trimester were heart defects (n = 34), central nervous system anomalies (n = 30), facial clefts (n = 19), abnormal hands (n = 13), and genitourinary anomalies (n = 9). Conclusions. Targeted sonography identified abnormal fetal anatomy or abnormal biometric measurements in 95% of fetuses with trisomy 13 in the second trimester after 17 weeks’ gestation. A biometric measurement below the fifth percentile was noted in nearly half of cases in the second trimester.

Key Words: aneuploidy • prenatal diagnosis • sonography • trisomy 13

Abbreviations: AC, abdominal circumference • BPD, biparietal diameter • CNS, central nervous system • FL, femur length







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Institute of Ultrasound in Medicine.